Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure contains a boronic ester group, making it suitable for Suzuki-Miyaura cross-coupling reactions, which are widely employed in forming carbon-carbon bonds during drug discovery. The piperazine moiety enhances solubility and binding affinity to biological targets, while the tert-butyloxycarbonyl (Boc) group serves as a protecting group for the piperazine nitrogen, allowing for selective and controlled deprotection and further functionalization. Commonly applied in the preparation of potential anticancer, anti-inflammatory, and central nervous system agents.